Table 2 |
|||
|
Median plasma adrenomedullin levels in patients with and without diabetic microangiopathy and control group |
|||
|
Group |
N |
Median AM(pg/ml) |
Confidence interval* |
|
|
|||
|
Nephropathy |
15 |
75 |
58.41-162.79 |
|
|
|||
|
Nephropathy + retinopathy |
5 |
200 |
23.02-348.98 |
|
|
|||
|
Nephropathy + neuropathy |
3 |
70 |
|
|
|
|||
|
Without MVC |
40 |
65 |
50.22 - 70.28 |
|
|
|||
|
Controls |
30 |
40 |
34.64 - 43.76 |
|
|
|||
|
*95th confidence interval |
|||
|
El-Habashy et al. Diabetology & Metabolic Syndrome 2010 2:12 doi:10.1186/1758-5996-2-12 |
|||
